Wenming Chen

10PUBLICATIONS
19CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPharmacogenomicsRegenerative medicine (incl. stem cells)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 28, 2026
Clinical Characteristics, Treatment Patterns, and Prognosis of Central Nervous System Involvement in Multiple Myeloma: A Multicenter Retrospective Study From China.

|Apr 15, 2025
Bortezomib, Mitoxantrone Hydrochloride Liposome, and Dexamethasone for Relapsed/Refractory Multiple Myeloma: A Multi-Center, Open-Label Phase I Trial.

Ya-Lan Zhou, Jin-Qiao Zhang, Wei Wang

|Jan 22, 2025
CM313 Monotherapy in Patients With Relapsed/Refractory Multiple Myeloma or Marginal Zone Lymphoma: A Multicenter, Phase 1 Dose-Escalation and Dose-Expansion Trial.

Huixing Zhou, Zhongxia Huang, Baijun Fang

|Apr 30, 2024
Assessment of prolonged proteasome inhibition through ixazomib-based oral regimen on newly diagnosed and first-relapsed multiple myeloma: A real-world Chinese cohort study.

Aijun Liu, Hong Yu, Rui Hou

|Dec 19, 2023
Efficacy and safety of generic pomalidomide plus low-dose dexamethasone in relapsed or refractory multiple myeloma: a multicenter, open-label, single-arm trial.

Huixing Zhou, Yafei Wang, Jiao Chen

|Apr 06, 2023
Prognostic nomogram for multiple myeloma early relapse after autologous stem cell transplant in the novel agent era.

Huixing Zhou, Yuan Jian, Juan Du

Pageof 2

Frequent Collaborators

3 joint publications

Huixing Zhou

3 joint publications

Zhiyao Zhang

2 joint publications

Li Bao

2 joint publications

Yuan Jian